This important Partnership between the world’s first cancer hospital and New Jersey’s premier hospital system exists to bring together expertise and scale to find more cures faster. With deep local roots, we share a unique ability to accelerate discoveries, advance the continuum of care and create new hope.
Today, we have aligned on following the most informed standards of care for many cancer types, including breast, lung, colon, prostate and non-Hodgkin lymphoma. Tomorrow, there will be even more to come as we continue to grow our Partnership.
Precision medicine tailors cancer treatment based upon the genetic understanding of a patient’s tumor. The knowledge that tumors have genetic mutations has led to targeted therapies that may block the spread of some cancers. Join Memorial Sloan Kettering and Hackensack Meridian Health for the latest Cancer Science Today online discussion to hear from two leading experts about the progress and potential of precision medicine.